Design and gene delivery activity of modified polyethylenimines

Advanced Drug Delivery Reviews

Volumn 53, Issue 3, 2001, Pages 341-358

  Kircheis, Ralf ^a   Wightman, Lionel ^a   Wagner, Ernst ^a  

^a BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

Gene transfer in vivo; PEI; Polyethylenimine; Targeting; Transferrin

Indexed keywords

DNA; DRUG THERAPY; ENZYMES; GENES;

BIOLOGICAL FLUIDS;

POLYMERS;

BETA GALACTOSIDASE; LUCIFERASE; MACROGOL; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; POLOXAMER; POLYETHYLENEIMINE DERIVATIVE; RECEPTOR; RECOMBINANT DNA; TRANSFERRIN; TRANSFERRIN RECEPTOR;

BODY FLUID; CELL NUCLEUS; DNA DRUG COMPLEX; DNA PROTEIN COMPLEX; DNA TRANSFECTION; DRUG COATING; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; ELECTRICITY; ENDOSOME; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TARGETING; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; SURFACE CHARGE; TUMOR;

ANIMALS; DNA; DRUG DELIVERY SYSTEMS; GENE TARGETING; HUMANS; POLYETHYLENEIMINE;

EID: 0035980982     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00202-2     Document Type: Review

References (111)

1. Nonviral gene therapy: The promise of genes as pharmaceutical products
2. Obstacles and advances in non-viral gene delivery
3. Direct gene transfer into mouse muscle in vivo
4. Expression of naked DNA in human, pig, and mouse skin
5. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment
6. In vivo gene electroporation and expression in rat liver
7. Electropermeabilization of skeletal muscle enhances gene transfer in vivo
8. Gene transfer with synthetic cationic amphiphiles: Prospects for gene therapy
9. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
10. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo - Polyethylenimine
11. Poly(ethylenimine) and its role in gene delivery
12. Ionization of polyethylenimine and polyallylamine at various pHs
13. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complex
14. Optimized galenics improve in vitro gene transfer with cationic molecules up to a thousand-fold
15. Polyethylenimines: A family of potent polymers for nucleic acid delivery
16. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells
17. Nanoscopic structure of DNA condensed for gene delivery
18. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system
19. PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery
20. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application
21. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo
22. Mechanism of polycation stimulation of pinocytosis
23. Biological activity of oligonucleotide-poly(L-lysine) conjugates: Mechanism of cell uptake
24. An electron microscopy study into the mechanism of gene transfer with lipopolyamines
25. Evidence for the role of proteoglycans in cation-mediated gene transfer
26. Mechanism of cationic lipoplex gene delivery
27. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system
28. Receptor-mediated gene delivery in vivo
29. Transferrin-polycation conjugates as carriers for DNA uptake into cells
30. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis
31. Receptor-mediated transport of DNA into eukaryotic cells
32. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand
33. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor
34. Targeting DNA to cells with basic fibroblast growth factor (FGF2)
35. A novel gene delivery system using EGF receptor-mediated endocytosis
36. Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor
37. Receptor-mediated gene transfer into T-lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex
38. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery
39. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes
40. Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFNgamma, or combination IL-2+IFNgamma
41. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems
42. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
43. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers
44. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
45. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels
46. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI)
47. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine
48. Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection
49. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway
50. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies
51. Glycerol enhancement of ligand-polylysine/DNA transfection
52. Rhinovirus mediated endosomal release of transfection complexes
53. In vitro gene delivery by degraded polyamidoamine dendrimers
54. Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier
55. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine
56. Polyethylenimine-based intravenous delivery of transgenes to mouse lung
57. Cellular and molecular barriers to gene transfer by a cationic lipid
58. Polyethylenimine but not cationic lipids promote transgene delivery to the nucleus in mammalian cells
59. Gene transfer into mammalian cells using histone-condensed plasmid DNA
60. Tracking the intracellular path of poly(ethylenimine) DNA complexes for gene delivery
61. Metabolic instability of plasmid DNA in the cytosol: A potential barrier to gene transfer
62. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus
63. DNA vector chemistry: The covalent attachment of signal peptides to plasmid DNA
64. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus
65. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA
66. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
67. Immunotherapy of malignancy by in vivo gene transfer into tumors
68. Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes
69. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo
70. Gene delivery into malignant cells in vivo by conjugated adenovirus/DNA complex
71. Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells
72. Nonviral gene delivery to the rat kidney with polyethylenimine
73. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo
74. In vivo delivery to tumors of DNA complexed with linear polyethylenimine
75. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
76. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA
77. The efficient expression of intravascularly delivered DNA in rat muscle
78. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant
79. Immunologic responses to gene transfer into mice via the polymeric immunoglobulin receptor
80. Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
81. CpG DNA and LPS induce distinct patterns of activation in human monocytes
82. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
83. Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs
84. Polycation/DNA complexes for in vivo gene delivery
85. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy
86. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes
87. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes
88. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration
89. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery
90. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
91. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration
92. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs
93. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes
94. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
95. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery
96. Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers
97. Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers
98. Protective copolymers for nonviral gene vectors: Synthesis, vector characterization and application in gene delivery
99. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin
100. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents
101. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle
102. Microvascular permeability of normal and neoplastic tissue
103. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
104. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery
105. In vitro and in vivo targeting of gene expression to melanoma cells
106. Targeting gene expression to hypoxic tumor cells
107. Cell-specific nuclear import of plasmid DNA
108. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo
109. Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery